| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TriSalus Life Sciences, Inc. | Director | Director Stock Option (right to buy) | 56,250 | 12 Jun 2025 | Direct | ||
| Old Ayala, Inc | Chief Medical Officer | Common Stock | 0 | 19 Jan 2023 | Direct | ||
| Old Ayala, Inc | Chief Medical Officer | Stock Option (right to buy) | 0 | 19 Jan 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TLSI | TriSalus Life Sciences, Inc. | 12 Jun 2025 | 1 | $0 | 4 | Director | 27 Jun 2025, 16:26 |
| TLSI | TriSalus Life Sciences, Inc. | 29 Jan 2025 | 2 | $0 | 4 | Director | 31 Jan 2025, 18:05 |
| TLSI | TriSalus Life Sciences, Inc. | 29 Jan 2025 | 0 | $0 | 3 | Director | 31 Jan 2025, 18:03 |
| /report/000121390023004542-gordon-gary-b-2023-01-19 | Old Ayala, Inc | 19 Jan 2023 | 4 | $0 | 4 | Chief Medical Officer | 23 Jan 2023, 20:00 |
| /report/000089924322018134-gordon-gary-b-2022-05-16 | Ayala Pharmaceuticals, Inc. | 16 May 2022 | 1 | $0 | 4 | Chief Medical Officer | 16 May 2022, 16:10 |
| /report/000089924322000879-gordon-gary-b-2022-01-03 | Ayala Pharmaceuticals, Inc. | 03 Jan 2022 | 1 | $0 | 4 | Chief Medical Officer | 05 Jan 2022, 15:05 |